Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases.

MLA

Primrose, John N., et al. “Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 33, no. 21, July 2015, pp. 2405–06. EBSCOhost, https://doi.org/10.1200/JCO.2014.60.1344.

APA

Primrose, J. N., Cunningham, D., Garden, O. J., Maughan, T. S., Pugh, S. A., Stanton, L., Falk, S. J., Rees, M., Finch-Jones, M., Valle, J. W., O’Reilly, D., Hornbuckle, J., Hickish, T., & Bridgewater, J. A. (2015). Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33(21), 2405–2406. https://doi.org/10.1200/JCO.2014.60.1344

Chicago

Primrose, John N, David Cunningham, O James Garden, Tim S Maughan, Siân A Pugh, Louise Stanton, Stephen J Falk, et al. 2015. “Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33 (21): 2405–6. doi:10.1200/JCO.2014.60.1344.